Area of Interest: Out-Licensing
What we are looking for:
Our products may present an opportunity for you – through a licensing agreement in your market, a co-marketing arrangement, or another chance to collaborate.
Our tamper-resistant formulation technology INTAC® represents an innovative approach to address the issues of abuse of prescription drugs. This novel technology platform for immediate release (IR) and modified release (MR) formulations can also be used for various non-opioid drugs prone to abuse. For more information, please see www.intac.grunenthal.com